vs
Profound Medical Corp.（PROF）与RETRACTABLE TECHNOLOGIES INC（RVP）财务数据对比。点击上方公司名可切换其他公司
RETRACTABLE TECHNOLOGIES INC的季度营收约是Profound Medical Corp.的1.6倍（$9.4M vs $6.0M），RETRACTABLE TECHNOLOGIES INC净利率更高（-24.9% vs -136.8%，领先111.9%）
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
Retractable Technologies Inc是一家专业医疗设备制造商，主打可回缩注射器、安全针头、静脉导管等一次性安全医疗产品，客户覆盖医疗机构、制药企业及公共卫生部门，产品可有效降低医护人员与患者的针刺伤害风险。
PROF vs RVP — 直观对比
营收规模更大
RVP
是对方的1.6倍
$6.0M
净利率更高
RVP
高出111.9%
-136.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.0M | $9.4M |
| 净利润 | $-8.2M | $-2.3M |
| 毛利率 | 66.8% | -16.2% |
| 营业利润率 | -123.3% | -81.7% |
| 净利率 | -136.8% | -24.9% |
| 营收同比 | — | 4.0% |
| 净利润同比 | — | -162.3% |
| 每股收益（稀释后） | $0.27 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PROFRVP
| Q4 25 | $6.0M | $9.4M | ||
| Q3 25 | $5.1M | $10.1M | ||
| Q2 25 | $2.0M | $10.4M | ||
| Q1 25 | $2.3M | $8.3M | ||
| Q4 24 | — | $9.1M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $6.0M | ||
| Q1 24 | — | $7.6M |
净利润PROFRVP
| Q4 25 | $-8.2M | $-2.3M | ||
| Q3 25 | $-8.0M | $371.0K | ||
| Q2 25 | $-15.7M | $-87.5K | ||
| Q1 25 | $-10.7M | $-10.5M | ||
| Q4 24 | — | $3.8M | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | — | $-14.2M | ||
| Q1 24 | — | $429.4K |
毛利率PROFRVP
| Q4 25 | 66.8% | -16.2% | ||
| Q3 25 | 77.7% | 16.7% | ||
| Q2 25 | 81.7% | -1.0% | ||
| Q1 25 | 79.2% | -0.0% | ||
| Q4 24 | — | -27.5% | ||
| Q3 24 | — | -0.1% | ||
| Q2 24 | — | -7.0% | ||
| Q1 24 | — | 25.0% |
营业利润率PROFRVP
| Q4 25 | -123.3% | -81.7% | ||
| Q3 25 | -176.2% | -36.2% | ||
| Q2 25 | -696.9% | -49.1% | ||
| Q1 25 | -477.0% | -56.4% | ||
| Q4 24 | — | -79.6% | ||
| Q3 24 | — | -49.6% | ||
| Q2 24 | — | -95.6% | ||
| Q1 24 | — | -39.3% |
净利率PROFRVP
| Q4 25 | -136.8% | -24.9% | ||
| Q3 25 | -157.7% | 3.7% | ||
| Q2 25 | -792.3% | -0.8% | ||
| Q1 25 | -458.1% | -126.6% | ||
| Q4 24 | — | 41.6% | ||
| Q3 24 | — | -18.6% | ||
| Q2 24 | — | -234.9% | ||
| Q1 24 | — | 5.7% |
每股收益（稀释后）PROFRVP
| Q4 25 | $0.27 | $-0.09 | ||
| Q3 25 | $0.26 | $0.01 | ||
| Q2 25 | $0.52 | $0.00 | ||
| Q1 25 | $0.36 | $-0.35 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.48 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $59.7M | $2.6M |
| 总债务越低越好 | $4.5M | $895.6K |
| 股东权益账面价值 | $66.4M | $74.4M |
| 总资产 | $77.5M | $142.6M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资PROFRVP
| Q4 25 | $59.7M | $2.6M | ||
| Q3 25 | $24.8M | $3.4M | ||
| Q2 25 | $35.2M | $3.0M | ||
| Q1 25 | $46.4M | $3.4M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $10.0M |
总债务PROFRVP
| Q4 25 | $4.5M | $895.6K | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $4.5M | — | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PROFRVP
| Q4 25 | $66.4M | $74.4M | ||
| Q3 25 | $32.1M | $76.8M | ||
| Q2 25 | $39.3M | $76.5M | ||
| Q1 25 | $50.8M | $76.6M | ||
| Q4 24 | — | $87.2M | ||
| Q3 24 | — | $83.5M | ||
| Q2 24 | — | $85.4M | ||
| Q1 24 | — | $99.7M |
总资产PROFRVP
| Q4 25 | $77.5M | $142.6M | ||
| Q3 25 | $42.3M | $146.4M | ||
| Q2 25 | $49.7M | $147.1M | ||
| Q1 25 | $60.9M | $149.3M | ||
| Q4 24 | — | $160.7M | ||
| Q3 24 | — | $157.8M | ||
| Q2 24 | — | $160.7M | ||
| Q1 24 | — | $176.0M |
负债/权益比PROFRVP
| Q4 25 | 0.07× | 0.01× | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $-596.5K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PROFRVP
| Q4 25 | $-6.6M | $-596.5K | ||
| Q3 25 | $-9.6M | $-1.3M | ||
| Q2 25 | $-13.7M | $-3.7M | ||
| Q1 25 | $-8.3M | $-1.5M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $-5.7M | ||
| Q2 24 | — | $-2.7M | ||
| Q1 24 | — | $-2.0M |
自由现金流PROFRVP
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $-4.1M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-1.4M | ||
| Q3 24 | — | $-6.5M | ||
| Q2 24 | — | $-2.8M | ||
| Q1 24 | — | $-2.2M |
自由现金流率PROFRVP
| Q4 25 | — | — | ||
| Q3 25 | — | -13.4% | ||
| Q2 25 | — | -38.9% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | -15.5% | ||
| Q3 24 | — | -63.0% | ||
| Q2 24 | — | -46.8% | ||
| Q1 24 | — | -29.6% |
资本支出强度PROFRVP
| Q4 25 | — | — | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 3.0% |
现金转化率PROFRVP
| Q4 25 | — | — | ||
| Q3 25 | — | -3.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -4.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
